SAMIR S KEBLAWI
Allopathic & Osteopathic Physicians|Pediatrics SPOKANE VALLEY, WA NPI 1790777472
Browse related groups: Allopathic & Osteopathic Physicians|Pediatrics WA PFIZER INC. All categories
General Payments — all program years on this page
$164.73
- Category: General Payments
- Program years: PY2024
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $164.73 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $164.73 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $35.64 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $27.17 | 1 |
| Merck Sharp & Dohme Corporation | $26.19 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24.62 | 1 |
| Phathom Pharmaceuticals, Inc. | $18.55 | 1 |
| Neurocrine BioSciences, Inc. | $17.08 | 1 |
| Novo Nordisk AS | $15.48 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $164.73 | 8 |
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1092752840 | Boston Scientific Corporation | $27.17 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097302421 | Novo Nordisk Inc | $15.48 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118157001 | Boehringer Ingelheim Pharmaceuticals, Inc. | $24.62 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1130969812 | PFIZER INC. | $13.20 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1130972726 | PFIZER INC. | $22.44 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141955863 | Merck Sharp & Dohme LLC | $26.19 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150868590 | Neurocrine Biosciences, Inc. | $17.08 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151080428 | Phathom Pharmaceuticals, Inc. | $18.55 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.